These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8811355)

  • 1. Correlates of protective immunity against HIV-1 infection in immunized chimpanzees.
    Murthy KK; Cobb EK; Rouse SR; Lunceford SM; Johnson DE; Galvan AR
    Immunol Lett; 1996 Jun; 51(1-2):121-4. PubMed ID: 8811355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active and passive immunization against HIV type 1 infection in chimpanzees.
    Murthy KK; Cobb EK; Rouse SR; McClure HM; Payne JS; Salas MT; Michalek GR
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S271-6. PubMed ID: 9814955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.
    Bruck C; Thiriart C; Fabry L; Francotte M; Pala P; Van Opstal O; Culp J; Rosenberg M; De Wilde M; Heidt P; Heeney J
    Vaccine; 1994 Sep; 12(12):1141-8. PubMed ID: 7998425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells.
    Fultz PN; Nara P; Barre-Sinoussi F; Chaput A; Greenberg ML; Muchmore E; Kieny MP; Girard M
    Science; 1992 Jun; 256(5064):1687-90. PubMed ID: 1609280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Where are we now with vaccines against AIDS?
    Schild GC; Stott EJ
    BMJ; 1993 Apr; 306(6883):947-8. PubMed ID: 8490466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids.
    Boyer JD; Cohen AD; Ugen KE; Edgeworth RL; Bennett M; Shah A; Schumann K; Nath B; Javadian A; Bagarazzi ML; Kim J; Weiner DB
    AIDS; 2000 Jul; 14(11):1515-22. PubMed ID: 10983638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees.
    Lockey TD; Slobod KS; Caver TE; D'Costa S; Owens RJ; McClure HM; Compans RW; Hurwitz JL
    Immunol Res; 2000; 21(1):7-21. PubMed ID: 10803879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus.
    Girard M; van der Ryst E; Barré-Sinoussi F; Nara P; Tartaglia J; Paoletti E; Blondeau C; Jennings M; Verrier F; Meignier B; Fultz PN
    Virology; 1997 May; 232(1):98-104. PubMed ID: 9185593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.
    Berman PW; Murthy KK; Wrin T; Vennari JC; Cobb EK; Eastman DJ; Champe M; Nakamura GR; Davison D; Powell MF; Bussiere J; Francis DP; Matthews T; Gregory TJ; Obijeski JF
    J Infect Dis; 1996 Jan; 173(1):52-9. PubMed ID: 8537682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees.
    Gibbs CJ; Peters R; Gravell M; Johnson BK; Jensen FC; Carlo DJ; Salk J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3348-52. PubMed ID: 2014254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.
    Barrett N; Eder G; Dorner F
    Biotechnol Ther; 1991; 2(1-2):91-106. PubMed ID: 1845126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial.
    Ugen KE; Boyer JD; Wang B; Bagarazzi M; Javadian A; Frost P; Merva MM; Agadjanyan MG; Nyland S; Williams WV; Coney L; Ciccarelli R; Weiner DB
    Vaccine; 1997 Jun; 15(8):927-30. PubMed ID: 9234550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.
    Pincus SH; Messer KG; Hu SL
    J Clin Invest; 1994 Jan; 93(1):140-6. PubMed ID: 8282780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cellular cytotoxicity against HIV-1 in sera of immunized chimpanzees.
    Belo M; Yagello M; Girard M; Greenlee R; Deslandres A; Barré-Sinoussi F; Gluckman JC
    AIDS; 1991 Feb; 5(2):169-76. PubMed ID: 2031689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge.
    Dumais N; Patrick A; Moss RB; Davis HL; Rosenthal KL
    J Infect Dis; 2002 Oct; 186(8):1098-105. PubMed ID: 12355360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees.
    Bagarazzi ML; Boyer JD; Ugen KE; Javadian MA; Chattergoon M; Shah A; Bennett M; Ciccarelli R; Carrano R; Coney L; Weiner DB
    Vaccine; 1998 Nov; 16(19):1836-41. PubMed ID: 9795389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Immunization with Recombinant Vaccinia Virus Prime and Intramuscular Protein Boost Provides Protection against Intrarectal Simian-Human Immunodeficiency Virus Challenge in Macaques.
    Thippeshappa R; Tian B; Cleveland B; Guo W; Polacino P; Hu SL
    Clin Vaccine Immunol; 2015 Dec; 23(3):204-12. PubMed ID: 26718849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.